DAILY UPDATE
August 3, 2023
Dear Valued Reader,

Time to hand the podium over to Michael Jorrin again... our own Doc Gumshoe is ready with part two of his update on the world of cancer treatment in 2023, just click below to catch up on what's happening... 


We don't generally offer sales or discounts at Stock Gumshoe, but I'm putting in an Early Adopter Discount for those who decide to try out our new Irregulars Plus+ Ad Free option this summer -- the price will bump up in a couple months, but every subscription we offer is always locked in, existing subscribers will never see their cost increase, so you can keep the discount price for as long as you like.

Check out our Irregulars Plus+ Ad Free subscription options now...

Questions?  Check out our FAQ page, or contact us.  Thanks!


ADVERTISEMENT

Prefer to talk investments instead of cancer?

I've gotten this "hidden AI stock" teaser pitch from the Oxford Club a bunch of times over the past week... it's about a company that already has a lot of revenue ($215 billion), holds a lot of patents, pays a dividend, and they say it trades under a "secret name" and is cheap, less than five bucks, and expects to have a "three digit" increase in that "ChatGPT" part of the business this year.  So what's that all about?

Well, sad to say, it's not really new... but the new "AI" pitches mean it's time for a thorough update from yours truly, just click below to...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe, its employees, or the author of this email. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. Please note that unsubscribing applies only to receiving emails, if you have a premium membership in the Stock Gumshoe Irregulars that membership will not automatically change or be canceled by clicking unsubscribe. Please contact us if you would like to change a paid membership.